Extracellular Superoxide Dismutase: Growth Promoter or Tumor Suppressor?

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Laukkanen, Mikko O ^a  

^a IRCCS SDN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL PROLIFERATION; CHEMICAL ACTIVATION; GENE TRANSFER; SIGNAL TRANSDUCTION;

EXTRACELLULAR SUPEROXIDE DISMUTASE; GROWTH MECHANISMS; GROWTH PROMOTERS; GROWTH REGULATION; INFLAMMATORY CELLS; KINASE ACTIVATION; SUPEROXIDE ANIONS; TUMOR SUPPRESSORS;

ENZYMES;

B RAF KINASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE; RAS PROTEIN; VASCULOTROPIN RECEPTOR; SUPEROXIDE DISMUTASE;

ANTIINFLAMMATORY ACTIVITY; CANCER INHIBITION; CARCINOGENESIS; CELL FUNCTION; CELL IMMORTALIZATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE OVEREXPRESSION; GROWTH REGULATION; HEART PROTECTION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL PROLIFERATION; ENZYMOLOGY; EXTRACELLULAR SPACE; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; CARCINOGENESIS; CELL PROLIFERATION; EXTRACELLULAR SPACE; HUMANS; HYDROGEN PEROXIDE; NEOPLASMS; SUPEROXIDE DISMUTASE;

EID: 84973303615     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/3612589     Document Type: Review

References (91)

1. S. Marklund, "A novel superoxide dismutase of high molecular weight from bovine liver, " Acta Chemica Scandinavica, vol. 27, no. 4, pp. 1458-1460, 1973.
2. S. L. Marklund, "Human copper-containing superoxide dismutase of high molecular weight, " Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 24 I, pp. 7634-7638, 1982.
3. J. M. McCord and I. Fridovich, "Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein), " The Journal of Biological Chemistry, vol. 244, no. 22, pp. 6049-6055, 1969.
4. M. C. Scrutton, "Purification and some properties of a protein containing bound manganese (avimanganin), " Biochemistry, vol. 10, no. 21, pp. 3897-3905, 1971.
5. R. A. Weisiger and I. Fridovich, "Superoxide dismutase. Organelle specificity, "The Journal of Biological Chemistry, vol. 248, no. 10, pp. 3582-3592, 1973.
6. T. Nagano, T. Hirano, and M. Hirobe, "Superoxide dismutase mimics based on iron in vivo, " The Journal of Biological Chemistry, vol. 264, no. 16, pp. 9243-9249, 1989.
7. M. Athar, M. Iqbal, and U. Giri, "Novel copper superoxide dismutase mimics and damage mediated by O2. ?, " Nutrition, vol. 11, no. 5, supplement, pp. 559-563, 1995.
8. I. Batinic-Haberle, Z. Rajic, A. Tovmasyan et al., "Diverse functions of cationicMn(III) N-substituted pyridylporphyrins, recognized as SOD mimics, " Free Radical Biology andMedicine, vol. 51, no. 5, pp. 1035-1053, 2011.
9. S. Miriyala, I. Spasojevic, A. Tovmasyan et al., "Manganese superoxide dismutase, MnSOD and its mimics, " Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1822, no. 5, pp. 794-814, 2012.
10. I. Batinic-Haberle, A. Tovmasyan, E. R. H. Roberts, Z. Vujaskovic, K. W. Leong, and I. Spasojevic, "SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways, " Antioxidants & Redox Signaling, vol. 20, no. 15, pp. 2372-2415, 2014.
11. M. O. Laukkanen, A. Kivelä, T. Rissanen et al., "Adenovirusmediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta, " Circulation, vol. 106, no. 15, pp. 1999-2003, 2002.
12. J. Sandström, P. Nilsson, K. Karlsson, and S. L. Marklund, "10-Fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain, "The Journal of Biological Chemistry, vol. 269, no. 29, pp. 19163-19166, 1994.
13. T. Adachi, H. Yamada, Y. Yamada et al., "Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface, " Biochemical Journal, vol. 313, no. 1, pp. 235-239, 1996.
14. M.-J. Kwon, K.-Y. Lee, H.-W. Lee, J.-H. Kim, and T.-Y. Kim, "SOD3 variant, R213G, altered SOD3 function, leading to ROSmediated inflammation and damage in multiple organs of premature aging mice, " Antioxidants & Redox Signaling, vol. 23, no. 12, pp. 985-999, 2015.
15. I. N. Zelko, M. W. Stepp, A. L. Vorst, and R. J. Folz, "Histone acetylation regulates the cell-specific and interferon-inducible expression of extracellular superoxide dismutase in human pulmonary arteries, " American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 5, pp. 953-961, 2011.
16. I. N. Zelko, M. R. Mueller, and R. J. Folz, "CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression, " Free Radical Biology and Medicine, vol. 48, no. 7, pp. 895-904, 2010.
17. M. O. Laukkanen, P. Lehtolainen, P. Turunen et al., "Rabbit extracellular superoxide dismutase: expression and effect on LDL oxidation, " Gene, vol. 254, no. 1-2, pp. 173-179, 2000.
18. J. J. Enghild, I. B. Thøgersen, T. D. Oury, Z. Valnickova, P. Højrup, and J. D. Crapo, "The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis, " The Journal of Biological Chemistry, vol. 274, no. 21, pp. 14818-14822, 1999.
19. M. O. Laukkanen, P. Leppänen, P. Turunen, E. Porkkala-Sarataho, J. T. Salonen, and S. Ylä-Herttuala, "Gene transfer of extracellular superoxide dismutase to atherosclerotic mice, " Antioxidants & Redox Signaling, vol. 3, no. 3, pp. 397-402, 2001.
20. S. V. Petersen, T. D. Oury, Z. Valnickova et al., "The dual nature of human extracellular superoxide dismutase: one sequence and two structures, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 24, pp. 13875-13880, 2003.
21. K. Karlsson, A. Edlund, J. Sandstrom, and S. L. Marklund, "Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase, " Biochemical Journal, vol. 290, no. 2, pp. 623-626, 1993.
22. J. Sandström, L. Carlsson, S. L. Marklund, and T. Edlund, "The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity, " The Journal of Biological Chemistry, vol. 267, no. 25, pp. 18205-18209, 1992.
23. F. Cammarota, G. de Vita, M. Salvatore, and M. O. Laukkanen, "Ras oncogene-mediated progressive silencing of extracellular superoxide dismutase in tumorigenesis, " BioMed Research International, vol. 2015, Article ID 780409, 13 pages, 2015.
24. J. P. Laurila, M. D. Castellone, A. Curcio et al., "Extracellular superoxide dismutase is a growth regulatory mediator of tissue injury recovery, " MolecularTherapy, vol. 17, no. 3, pp. 448-454, 2009.
25. R. H. Gottfredsen, U. G. Larsen, J. J. Enghild, and S. V. Petersen, "Hydrogen peroxide induce modifications of human extracellular superoxide dismutase that results in enzyme inhibition, " Redox Biology, vol. 1, no. 1, pp. 24-31, 2013.
26. P.-O. Sjoquist, L. Carlsson, G. Jonason, S. L. Marklund, and T. Abrahamsson, "Cardioprotective effects of recombinant human extracellular-superoxide dismutase type C in rat isolated heart subjected to ischemia and reperfusion, " Journal of Cardiovascular Pharmacology, vol. 17, no. 4, pp. 678-683, 1991.
27. G. Wahlund, S. L. Marklund, and P.-O. Sjöquist, "Extracellularsuperoxide dismutase type C (EC-SOD C) reduces myocardial damage in rats subjected to coronary occlusion and 24 hours of reperfusion, " Free Radical Research Communications, vol. 17, no. 1, pp. 41-47, 1992.
28. T. Abrahamsson, U. Brandt, S. L. Marklund, and P.-O. Sjoqvist, "Vascular bound recombinant extracellular superoxide dismutase typeCprotects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation, " Circulation Research, vol. 70, no. 2, pp. 264-271, 1992.
29. P.-O. Sjoquist and S. L. Marklund, "Endothelium bound extracellular superoxide dismutase type C reduces damage in reperfused ischaemic rat hearts, " Cardiovascular Research, vol. 26, no. 4, pp. 347-350, 1992.
30. P. F. Leite, A. Danilovic, P. Moriel et al., "Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 12, pp. 2197-2202, 2003.
31. E. P. Chen, H. B. Bittner, R. D. Davis, R. J. Folz, and P. VanTrigt, "Extracellular superoxide dismutase transgene overexpression preserves postischemic myocardial function in isolated murine hearts, " Circulation, vol. 94, no. 9, supplement II, pp. 412-417, 1996.
32. Q. Li, R. Bolli, Y. Qiu, X.-L. Tang, Y. Guo, and B. A. French, "Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction, " Circulation, vol. 103, no. 14, pp. 1893-1898, 2001.
33. K. Ozumi, H. Tasaki, H. Takatsu et al., "Extracellular superoxide dismutase overexpression reduces cuff-induced arterial neointimal formation, " Atherosclerosis, vol. 181, no. 1, pp. 55-62, 2005.
34. Z. Qian, M. Haessler, J. A. Lemos et al., "Targeting vascular injury usingHantavirus-pseudotyped lentiviral vectors, " Molecular Therapy, vol. 13, no. 4, pp. 694-704, 2006.
35. F. Kamezaki, H. Tasaki, K. Yamashita et al., "Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats, " American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 2, pp. 219-226, 2008.
36. J. P. Laurila, L. E. Laatikainen, M. D. Castellone, and M. O. Laukkanen, "SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression, " PLoS ONE, vol. 4, no. 6, Article ID e5786, 2009.
37. S.-Q. He, Y.-H. Zhang, S. K. Venugopal et al., "Delivery of antioxidative enzyme genes protects against ischemia/reperfusioninduced liver injury in mice, " Liver Transplantation, vol. 12, no. 12, pp. 1869-1879, 2006.
38. J. H. Bräsen, O. Leppänen, M. Inkala et al., "Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atheroscleroticWatanabe heritable hyperlipidemic rabbit aorta, " Journal of the American College of Cardiology, vol. 50, no. 23, pp. 2249-2253, 2007.
39. L. E. Laatikainen, M. Incoronato, M. D. Castellone, J. P. Laurila, M. Santoro, and M. O. Laukkanen, "SOD3 decreases ischemic injury derived apoptosis through phosphorylation of Erk1/2, Akt, and Foxo3a, " PLoS ONE, vol. 6, no. 8, Article ID e24456, 2011.
40. C. L. Fattman, L. M. Schaefer, and T. D. Oury, "Extracellular superoxide dismutase in biology and medicine, " Free Radical Biology and Medicine, vol. 35, no. 3, pp. 236-256, 2003.
41. T. Fukai, R. J. Folz, U. Landmesser, and D. G. Harrison, "Extracellular superoxide dismutase and cardiovascular disease, " Cardiovascular Research, vol. 55, no. 2, pp. 239-249, 2002.
42. I. N. Zelko, T. J. Mariani, and R. J. Folz, "Superoxide dismutase multigene family: a comparison of theCuZn-SOD(SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression, " Free Radical Biology and Medicine, vol. 33, no. 3, pp. 337-349, 2002.
43. T. Fukai and M. Ushio-Fukai, "Superoxide dismutases: role in redox signaling, vascular function, and diseases, " Antioxidants & Redox Signaling, vol. 15, no. 6, pp. 1583-1606, 2011.
44. Z. Qin, K. J. Reszka, T. Fukai, and N. L. Weintraub, "Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD, " Translational Research, vol. 151, no. 2, pp. 68-78, 2008.
45. J. Oshikawa, N. Urao, H. W. Kim et al., "Extracellular SODderived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice, " PLoS ONE, vol. 5, no. 4, Article ID e10189, 2010.
46. L. M. Carlsson, J. Jonsson, T. Edlund, and S. L. Marklund, "Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia, " Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 14, pp. 6264-6268, 1995.
47. M. C. Gongora, H. E. Lob, U. Landmesser et al., "Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome, " The American Journal of Pathology, vol. 173, no. 4, pp. 915-926, 2008.
48. A. S. Abdel-Mageed, A. J. Senagore, D. W. Pietryga et al., "Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice, " Blood, vol. 113, no. 5, pp. 1201-1203, 2009.
49. J. Gan, F. Meng, X. Zhou et al., "Hematopoietic recovery of acute radiation syndrome by human superoxide dismutase-expressing umbilical cord mesenchymal stromal cells, " Cytotherapy, vol. 17, no. 4, pp. 403-417, 2015.
50. N. Ahmadbeigi, M. Soleimani, M. Vasei et al., "Isolation, characterization, and transplantation of bone marrow-derived cell components with hematopoietic stemcell niche properties, " Stem Cells andDevelopment, vol. 22, no. 23, pp. 3052-3061, 2013.
51. S. Méndez-Ferrer, T. V. Michurina, F. Ferraro et al., "Mesenchymal and haematopoietic stem cells forma unique bone marrow niche, " Nature, vol. 466, no. 7308, pp. 829-834, 2010.
52. H. B. Suliman, M. Ali, and C. A. Piantadosi, "Superoxide dismutase-3 promotes full expression of the EPO response to hypoxia, " Blood, vol. 104, no. 1, pp. 43-50, 2004.
53. M. Sundaresan, Z.-X. Yu, V. J. Ferrans, K. Irani, and T. Finkel, "Requirement for generation of H2O2 for platelet-derived growth factor signal transduction, " Science, vol. 270, no. 5234, pp. 296-299, 1995.
54. C. Lennicke, J. Rahn, R. Lichtenfels, L. A. Wessjohann, and B. Seliger, "Hydrogen peroxide-production, fate and role in redox signaling of tumor cells, " Cell Communication and Signaling, vol. 13, article 39, 2015.
55. Y. S. Bae, S. W. Kang, M. S. Seo et al., "Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation, " The Journal of Biological Chemistry, vol. 272, no. 1, pp. 217-221, 1997.
56. J. M. Denu and K. G. Tanner, "Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation, " Biochemistry, vol. 37, no. 16, pp. 5633-5642, 1998.
57. C. E. Paulsen, T. H. Truong, F. J. Garcia et al., "Peroxidedependent sulfenylation of the EGFR catalytic site enhances kinase activity, " Nature Chemical Biology, vol. 8, no. 1, pp. 57-64, 2012.
58. J. Mitsushita, J. D. Lambeth, and T. Kamata, "The superoxidegenerating oxidase Nox1 is functionally required for Ras oncogene transformation, " Cancer Research, vol. 64, no. 10, pp. 3580-3585, 2004.
59. K. Nakamura, T. Hori, N. Sato, K. Sugie, T. Kawakami, and J. Yodoi, "Redox regulation of a src family protein tyrosine kinase p56lck in T cells, " Oncogene, vol. 8, no. 11, pp. 3133-3139, 1993.
60. F. Cammarota and M. O. Laukkanen, "Mesenchymal stem/stromal cells in stromal evolution and cancer progression, " Stem Cells International, vol. 2016, Article ID 4824573, 11 pages, 2016.
61. J. P. Fruehauf and F. L. Meyskens Jr., "Reactive oxygen species: a breath of life or death" Clinical Cancer Research, vol. 13, no. 3, pp. 789-794, 2007.
62. L. E. Laatikainen, M. D. Castellone, A. Hebrant et al., "Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer, " Endocrine-Related Cancer, vol. 17, no. 3, pp. 785-796, 2010.
63. M. D. Castellone, A. Langella, S. Cantara et al., "Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis, " Antioxidants & Redox Signaling, vol. 21, no. 10, pp. 1460-1474, 2014.
64. A.-M. Svensk, Y. Soini, P. Pääkkö, P. Hirvikoski, and V. L. Kinnula, "Differential expression of superoxide dismutases in lung cancer, " American Journal of Clinical Pathology, vol. 122, no. 3, pp. 395-404, 2004.
65. H. Yokoe, H. Nomura, Y. Yamano et al., "Alteration of extracellular superoxide dismutase expression is associated with an aggressive phenotype of oral squamous-cell carcinoma, " Experimental and Therapeutic Medicine, vol. 1, no. 4, pp. 585-590, 2010.
66. B. R. O'Leary, M. A. Fath, A. M. Bellizzi et al., "Loss of SOD3 (EcSOD) expression promotes an aggressive phenotype in human pancreatic ductal adenocarcinoma, " Clinical Cancer Research, vol. 21, no. 7, pp. 1741-1751, 2015.
67. C. A. Wang, J. C. Harrell, R. Iwanaga, P. Jedlicka, and H. L. Ford, "Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3, " Breast Cancer Research, vol. 16, no. 5, article 462, 2014.
68. X. Zhang, W.-L. Ng, P. Wang et al., "MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNF , " Cancer Research, vol. 72, no. 18, pp. 4707-4713, 2012.
69. T. Fukai, M. R. Siegfried, M. Ushio-Fukai, Y. Cheng, G. Kojda, and D. G. Harrison, "Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training, " The Journal of Clinical Investigation, vol. 105, no. 11, pp. 631-1639, 2000.
70. T. Adachi, T. Toishi, E. Takashima, and H. Hara, "Infliximab neutralizes the suppressive effect of TNF on expression of extracellular-superoxide dismutase in vitro, " Biological and Pharmaceutical Bulletin, vol. 29, no. 10, pp. 2095-2098, 2006.
71. T. Kamiya, H. Hara, H. Yamada, H. Imai, N. Inagaki, and T. Adachi, "Cobalt chloride decreases EC-SOD expression through intracellular ROS generation and p38-MAPK pathways in COS7 cells, " Free Radical Research, vol. 42, no. 11-12, pp. 949-956, 2008.
72. M. O. Laukkanen, S. Mannermaa, M. O. Hiltunen et al., "Local hypomethylation in atherosclerosis found in rabbit ec-sod gene, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 9, pp. 2171-2178, 1999.
73. M. L. Teoh-Fitzgerald, M. P. Fitzgerald, W. Zhong, R. W. Askeland, and F. E. Domann, "Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis, " Oncogene, vol. 33, no. 3, pp. 358-368, 2014.
74. T. Kamiya, M. Machiura, J. Makino, H. Hara, I. Hozumi, and T. Adachi, "Epigenetic regulation of extracellular-superoxide dismutase in humanmonocytes, " Free Radical Biology &Medicine, vol. 61, pp. 197-205, 2013.
75. M. O. Laukkanen, F. Cammarota, T. Esposito, M. Salvatore, and M. D. Castellone, "Extracellular superoxide dismutase regulates the expression of small GTPase regulatory proteins GEFs, GAPs, and GDI, " PLoS ONE, vol. 10, no. 3, Article IDe0121441, 2015.
76. M. Tanaka, K. Kogawa, K. Nakamura et al., "Anti-metastatic gene therapy utilizing subcutaneous inoculation of EC-SOD gene transduced autologous fibroblast suppressed lung metastasis of Meth-A cells and 3LL cells in mice, " GeneTherapy, vol. 8, no. 2, pp. 149-156, 2001.
77. M. D. Wheeler, O. M. Smutney, and R. J. Samulski, "Secretion of extracellular superoxide dismutase from muscle transduced with recombinant adenovirus inhibits the growth of B16 melanomas in mice, " Molecular Cancer Research, vol. 1, no. 12, pp. 871-881, 2003.
78. M. L. T. Teoh, W. Sun, B. J. Smith, L. W. Oberley, and J. J. Cullen, "Modulation of reactive oxygen species in pancreatic cancer, " Clinical Cancer Research, vol. 13, no. 24, pp. 7441-7450, 2007.
79. M. L. T. Teoh, M. P. Fitzgerald, L. W. Oberley, and F. E. Domann, "Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion, " Cancer Research, vol. 69, no. 15, pp. 6355-6363, 2009.
80. M. O. Laukkanen, P. Leppanen, P. Turunen, T. Tuomisto, J. Naarala, and S. Yla-Herttuala, "EC-SOD gene therapy reduces paracetamol-induced liver damage in mice, " Journal of Gene Medicine, vol. 3, no. 4, pp. 321-325, 2001.
81. S. Matsuoka, M. Huang, and S. J. Elledge, "Linkage of ATM to cell cycle regulation by the Chk2 protein kinase, " Science, vol. 282, no. 5395, pp. 1893-1897, 1998.
82. G. D'Uva, S. Bertoni, M. Lauriola et al., "Beta-catenin/HuR post-transcriptional machinery governs cancer stem cell features in response to hypoxia, " PLoS ONE, vol. 8, no. 11, Article ID e80742, 2013.
83. J. Y. Leung, F. T. Kolligs, R. Wu et al., "Activation of AXIN2 expression by catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling, " The Journal of Biological Chemistry, vol. 277, no. 24, pp. 21657-21665, 2002.
84. Z. A. Sibenaller, J. L. Welsh, C. Du et al., "Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1 in pancreatic cancer, " Free Radical Biology & Medicine, vol. 69, pp. 357-366, 2014.
85. C. J. Sarkisian, B. A. Keister, D. B. Stairs, R. B. Boxer, S. E. Moody, and L. A. Chodosh, "Dose-dependent oncogeneinduced senescence in vivo and its evasion during mammary tumorigenesis, " Nature Cell Biology, vol. 9, no. 5, pp. 493-505, 2007.
86. R. DiMicco, M. Fumagalli, and F. d'Adda di Fagagna, "Breaking news: high-speed race ends in arrest-how oncogenes induce senescence, " Trends in Cell Biology, vol. 17, no. 11, pp. 529-536, 2007.
87. J. Bartek, J. Bartkova, and J. Lukas, "DNA damage signalling guards against activated oncogenes and tumour progression, " Oncogene, vol. 26, no. 56, pp. 7773-7779, 2007.
88. J. Tcherkezian and N. Lamarche-Vane, "Current knowledge of the large RhoGAP family of proteins, " Biology of the Cell, vol. 99, no. 2, pp. 67-86, 2007.
89. J. L. Bos, H. Rehmann, and A. Wittinghofer, "GEFs and GAPs: critical elements in the control of small G proteins, " Cell, vol. 129, no. 5, pp. 865-877, 2007.
90. C. DerMardirossian and G. M. Bokoch, "GDIs: central regulatory molecules in Rho GTPase activation, " Trends in Cell Biology, vol. 15, no. 7, pp. 356-363, 2005.
91. Y. Song, N. Driessens, M. Costa et al., "Roles of hydrogen peroxide in thyroid physiology and disease, " Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 10, pp. 3764-3773, 2007.